Main menu

Targeted nanopore sequencing using hybridisation probes reveals immune escape polymorphisms in malaria vaccine candidates

MALARIA

  • Caused by eukaryotic parasites (Plasmodium spp.)
  • Transmitted by anopheline mosquitoes
  • Major cause, and effect of poverty worldwide
  • Increasing resistance to interventions

MALARIA VACCINE DEVELOPMENT

  • Only one candidate has passed Phase 2 trials (RTS,S based on Circumsporozoite Protein, CSP)
  • Partial and short-lived efficacy in infants after 4 doses
  • Evidence of immune escape

PROBLEM:

  • Diverse antigens
  • Immune escape
  • Which polymorphisms?

SOLUTION:

  • Discover polymorphisms associated with immune escape
  • Targeted sequencing using Nanopore
  • Samples from longitudinal cohorts from Papua New Guinea

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag